Literature DB >> 6348034

Monoamine oxidase inhibitors: a review.

G D Tollefson.   

Abstract

Current knowledge about monoamine oxidase (MAO) inhibitors is reviewed, with particular attention to the mode of action, prognostic indicators, treatment protocol, response prediction, toxicity, and untoward drug interactions. The MAO inhibitors are often effective in the treatment of affective disorders, anxiety states, and phobias.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6348034

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

Review 1.  Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.

Authors:  G B Baker; R T Coutts; K F McKenna; R L Sherry-McKenna
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

Review 2.  [Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities].

Authors:  H-J Möller
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

Review 3.  Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies.

Authors:  R Amrein; T W Güntert; J Dingemanse; T Lorscheid; M Stabl; W Schmid-Burgk
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 4.  Monoamine oxidase inhibitor update. Potential adverse food and drug interactions.

Authors:  S B Lippman; K Nash
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

Review 5.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 6.  Treatment of patients with chronic fatigue syndrome.

Authors:  N M Gantz; G P Holmes
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

Review 7.  Adverse drug interactions.

Authors:  M J Brodie; J Feely
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

8.  Electroconvulsive therapy: physiological and anaesthetic considerations.

Authors:  R J Marks
Journal:  Can Anaesth Soc J       Date:  1984-09

Review 9.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

10.  Urinary excretion of bioactive amines and their metabolites in psychiatric patients receiving phenelzine.

Authors:  K F McKenna; G B Baker; R T Coutts
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.